Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 515


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 

  Table of Contents  
Year : 2012  |  Volume : 53  |  Issue : 4  |  Page : 179-183  

Hormones in pregnancy

1 Department of Obstetrics and Gynecology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
2 Air Force Hospital, Nathu Singh Road, Kanpur Cantt, Uttar Pradesh, India

Date of Web Publication21-Feb-2013

Correspondence Address:
Navneet Magon
Head, Department of Obstetrics and Gynecology, Air Force Hospital, Nathu Singh Road, Kanpur Cantt, U.P
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0300-1652.107549

Rights and Permissions

The endocrinology of human pregnancy involves endocrine and metabolic changes that result from physiological alterations at the boundary between mother and fetus. Progesterone and oestrogen have a great role along with other hormones. The controversies of use of progestogen and others are discussed in this chapter. Progesterone has been shown to stimulate the secretion of Th2 and reduces the secretion of Th1 cytokines which maintains pregnancy. Supportive care in early pregnancy is associated with a significant beneficial effect on pregnancy outcome. Prophylactic hormonal supplementation can be recommended for all assisted reproduction techniques cycles. Preterm labor can be prevented by the use of progestogen. The route of administration plays an important role in the drug's safety and efficacy profile in different trimesters of pregnancy. Thyroid disorders have a great impact on pregnancy outcome and needs to be monitored and treated accordingly. Method of locating review: Pubmed, scopus

Keywords: Oestrogen, hormones, progesterone, thyroid

How to cite this article:
Kumar P, Magon N. Hormones in pregnancy. Niger Med J 2012;53:179-83

How to cite this URL:
Kumar P, Magon N. Hormones in pregnancy. Niger Med J [serial online] 2012 [cited 2023 Dec 8];53:179-83. Available from: https://www.nigeriamedj.com/text.asp?2012/53/4/179/107549

   Introduction Top

Steroid hormones like progesterone have been extensively studied in the literature with controversies in early pregnancy usage with varied literature. The role in preventing abortions, recurrent pregnancy loss and preterm labor has been the aim of the review. Role of supplementation of oestrogen and progesterone in assisted reproduction has been analysed. Factors may be connected to the alterations in the metabolic pathway. Adequate levels of circulating thyroid hormones are of primary importance for normal reproductive function

Steroid hormone production and uses


Progesterone is largely produced by the corpus luteum until about 10 weeks of gestation. [1] A study in ovarian failure and Assisted reproduction it was shown that one hundred mg of P were probably a supraphysiological dose to support pregnancy 6 to 8 weeks after conception. The fetoplacental unit was competent from 10 to 12 weeks' gestation. [2] When the pregnancy reaches term gestation, progesterone levels range from 100-200 ng/ml and the placenta produces about 250 mg/day. Almost all of the progesterone produced by the placenta enters the placenta, contrast to oestrogen. Progesterone production is independent of he precursor available, fetal status including the wellbeing.

In early pregnancy, the maternal levels of 17 a-hydroxyprogesterone rise, marking the activity of the corpus luteum. By the tenth week of gestation, this compound has returned to baseline levels, indicating that the placenta has little 17a hydroxylase activity. However, beginning about the 32 nd week there is a second, more gradual rise in 17a-hydroxyprogesterone due to placental utilization of fetal precursors. This is relevant to understand prevention of preterm labor. Progesterone is also important in suppressing the maternal immunologic response to fetal antigens, thereby preventing maternal rejection of the trophoblast. And, of course, progesterone prepares and maintains the endometrium to allow implantation earlier. Studies have shown that the human corpus luteum makes significant amounts of estradiol, but it is progesterone and not oestrogen that is required for successful implantation. [3]


The placenta does not have all the necessary enzymes to make oestrogens from cholesterol, or even progesterone. Human trophoblast lack 17-hydroxylase and therefore cannot convert C21-steroids to C19-steroids, the immediate precursors of oestrogen. To bypass this deficit, dehydroisoandrosterone sulfate (DHA) from the fetal adrenal is converted to estradiol-17ί by trophoblasts. In its key location as a way station between mother and fetus, placenta can use precursors from either mother or fetus to circumvent its own deficiencies in enzyme activities. Hormones act as catalysts for chemical changes at the cellular level that are necessary for growth, development and energy. Fetus lacks 3 B hydroxysteroid dehydrogenase-hence unable to produce progesterone-borrows from placenta. In return, fetus give placenta what it lacks (19 Carbon compounds)-precursor of oestrogen.

Protein hormones

Protein hormones are: Human placental lactogen (hPL), Human chorionic gonadotropin (hCG), Adrenocorticotropic (ACTH), Growth hormone variant (hGH-V), Parathyroid hormone-related protein (PTH-rP), Calcitonin, Relaxin, Inhibins Activins, Atrial natriuretic peptide, Hypothalamic-like releasing and inhibiting hormones, Thyrotropin releasing hormone (TRH), Gonadotropin releasing hormone (GnRH), Corticotropin-releasing hormone (CRH), Somatostatin, Growth hormone-releasing hormone (GHRH), alpha fetoprotein, prolactin, relaxin and other decidual proteins. Due to the comprehensiveness of the choices to describe hormones, clinical importance of hCG relevant for therapy is discussed in this chapter.

Human chorionic gonadotropin

The most widely studied trophoblast hormone product is hCG. In pregnancy this glycoprotein is critical since it rescues the corpus luteum from involution, and this maintains progesterone secretion by the ovarian granulosa cells. Its usefulness as a diagnostic marker of pregnancy stems from the fact that it may be one of the earliest secreted products of the conceptus. In pregnancy, placental production of hCG is at its peak between the eighth to the tenth week of gestation, and tends to plateau at a lower level for the remainder of pregnancy.

The only definitely known function for hCG is support of the corpus luteum (CL), taking over for LH on about the eighth day after ovulation, 1 day after implantation, when b-hCG first can be detected in maternal blood. At 8 cell stage, hCG has been detected in the embryo using molecular biology techniques.

Implantation occurs 5-6 days after ovulation and hCG must appear by 10 days of ovulation (4 days after ovulation) to rescue corpus luteum. Hence, Blastocyst should implant in a narrow window of time. The hCG stimulation of CL has a daily secretion of 25 mg of P and 0.5 mg of E2. hCG gene expression is present in both cytotrophoblast and syncytiotrophoblast, but it is synthesized mainly in the syncytiotrophoblast. The maternal circulating hCG concentration is approximately 100 IU/L at the time of the expected but missed menses. A maximal level of about 100,000 IU/L in the maternal circulation is reached at 8-10 weeks of gestation. There are two clinical conditions in which blood hCG titers are especially helpful: Trophoblastic disease and ectopic pregnancies. Trophoblastic disease is distinguished by very high b-hCG levels (3-100 times higher than normal pregnancy). Ectopic production of a-and b-hCG by non-trophoblastic tumours is rare, but does occur.

The Human placental lactogen (hPL) is secreted primarily into the maternal circulation, most of its functions occur at sites of action in maternal tissues. Human placental lactogen is thought to be responsible for the marked rise in maternal plasma insulin-like growth factor-1 (IGF-1) concentrations as the pregnancy approaches term. Human placental lactogen exerts metabolic effects during pregnancy, via IGF-I. It is associated with insulin resistance, enhances insulin secretion which stimulates lipolysis, increases circulating free fatty acids, and inhibits gluconeogenesis; in effect, it antagonizes insulin action, induces glucose intolerance, as well as lipolysis and proteolysis in the maternal system. Hence the role of universal screening for abnormal blood sugar in the beginning of the third trimester is emphasized in clinical practice.

In the fetus calcium concentrations, are regulated by the movement of calcium, across the placenta, from the maternal compartment. In order to maintain fetal bone growth, the maternal compartment undergoes adjustments that provide a net transfer of sufficient calcium to the fetus. Maternal compartment changes that permit calcium accumulation include increases in maternal dietary intake, increases in maternal D3 levels, and increases in parathyroid hormone levels.

Progesterone supplement in pregnancy: An immunologic therapy

There are several studies to understand the maintenance of pregnancy by progesterone. Progesterone has been shown to increase the cytokines produced by Th2 cells which predominate over those produced by Th1 cells, resulting in the maintenance of pregnancy. Th2 cells are dominant within the decidua in early pregnancy in humans. The Th2-derived cytokines, IL-4 and IL-6, induce the release of hCG from trophoblasts and the hCG stimulates progesterone production from corpus luteum in pregnancy. Progesterone has been shown to stimulate the secretion of Th2 and reduces the secretion of Th1 cytokines. Thus, maintenance of pregnancy has been attributed to Th2 type cytokine. This role in controlling the immune and endocrine system which promotes the function of the trophoblasts at the implantation site seems interesting. [4] Use of progestogen in threatened abortion is controversial. [5]

Progesterone for recurrent miscarriage

Progestogen has been used for several years even before there was knowledge of the immunomodulatory properties of progesterone. Since that time, studies of differing quality have been carried out to prove the benefits of progestogen supplementation in affected women. A study on 146 women who presented with mild or moderate vaginal bleeding during the first trimester of pregnancy was randomized to receive oral dydrogesterone (10 mg b.i.d.) (n=86) or no treatment (n=60). Dydrogesterone was continued until 1 week after the bleeding had stopped. The incidence of miscarriage was significantly lower in the dydrogesterone group than in the untreated group (17.5% vs. 25%; P<0.05). [6] The majority of cited clinical trials revealed a trend to improved pregnancies and increased live birth rates in the progestogen treatment group, but unfortunately, many studies had poor designs and methodical weaknesses. [7] Several studies have shown that supportive care in early pregnancy is associated with a significant beneficial effect on pregnancy outcome. Women with otherwise unexplained recurrent pregnancy loss should be counselled regarding the potential for successful pregnancy without any treatment except supportive therapy such as folic acid or vitamin supplementation. [7]],[[8] The route of Progestogen administration are in various formulations, but it is generally recommend the exclusive use of progestogen without any (anti-) androgenic or (anti-) oestrogenic effect. Progestogen supplementation is available as vaginal suppositories (0.4 g/day, preferably in the evening because natural progesterone can cause tiredness), intramuscular injection (250 mg hydroxyprogesterone weekly) or oral intake (e.g. 10 mg dydrogesterone, the stereo-isomer of natural progesterone. [9]

Progesterone supplementation following assisted reproductive technology

The use of the progesterone supplementation in ART cycles has better clarity. [10] The duration of progesterone supplementation following reproductive technology (ART) has been studied in a retrospective cohort study. One group had progesterone supplementation through the first trimester of pregnancy (first trimester protocol) till 12 weeks and the second group had the progesterone discontinued after a positive beta hCG test 2 weeks after retrieval (luteal protocol). A similar rate of clinical pregnancies occurred at 7 weeks (81.8% luteal protocol vs. 85.8% first trimester protocol) and for live birth rates (76.8% luteal protocol vs. 75.0% first trimester protocol). There was a trend toward a higher rate of pregnancy loss after 7 weeks in the first trimester protocol group occurred (15.5% vs. 4.4%), indicating that first trimester progesterone supplementation may support early pregnancy through 7 weeks by delaying miscarriage but does not improve live birth rates. There are randomized trials supporting the routine use of luteal support in ART cycles using GnRH agonists or antagonists. Fifty-nine studies were included in a review to evaluate the luteal phase support with hCG compared to placebo or no treatment, in terms of increased ongoing pregnancy rates. Luteal phase support with hCG or progesterone after assisted reproduction results in an increased pregnancy rate. HCG does not provide better results than progesterone, and is associated with a greater risk of OHSS when used with GnRHa. The optimal route of progesterone administration has not yet been established. [11] A review showed a significant effect in favour of progesterone for luteal phase support, favouring synthetic progesterone over micronized progesterone. [12]

Prevention of recurrent preterm delivery by

17 alpha-hydroxyprogesterone caproate

Preterm delivery should be anticipated and prevented to decrease perinatal morbidity and mortality. Those women who have had a spontaneous preterm delivery earlier are at greatly increased risk for preterm delivery in subsequent pregnancies. The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. A double-blind, placebo-controlled trial involving pregnant women with a documented history of spontaneous preterm delivery was done. [13] A total of 19 clinical centers were taken for the study and pregnant women at 16 to 20 weeks of gestation were included and were randomly assigned by a central data center, in a 2:1 ratio, to receive either weekly injections of 250 mg of 17P or weekly injections of an inert oil placebo; injections were continued until delivery or to 36 weeks of gestation. Treatment with 17P significantly reduced the risk of delivery at less than 37 weeks of gestation which was 36.3 percent in the progesterone group vs. 54.9 percent in the placebo group; relative risk, delivery at less than 35 weeks of gestation was 20.6 percent vs. 30.7 percent; and delivery at less than 32 weeks of gestation was 11.4 percent vs. 19.6 percent. The incidence of necrotizing enterocolitis, intraventricular hemorrhage in infants of women treated with 17P had significantly lower rates of and need for supplemental oxygen. Hence, the study concluded that weekly injections of 17P resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants. One double blind randomized placebo controlled trials reported lower preterm birth rate with the use of either intramuscular 17 alpha-hydroxyprogesterone caproate (17P) or intravaginal micronized progesterone suppositories in women at risk for preterm delivery. [14] The half-life of 17P was estimated to be approximately 7.8 days. The route of administration plays an important role in the drug's safety and efficacy profile. Oral progesterone has not been used for prevention of preterm labor because of its first-pass hepatic metabolism, and there is a lack of data on efficacy, high side-effect profile, and because of extreme variability in plasma concentrations. Vaginal administration of progesterone avoids first-pass hepatic metabolism and is associated with rapid absorption, high bioavailability, and local endometrial effects. [15] Vaginal route offers no local pain and few side effects, it is associated with variable blood concentrations. [16] To study the efficacy of progesterone for maintenance tocolytic therapy after threatened preterm labor was done in a randomized controlled trial. [17] The study was on 70 women who presented with symptoms of threatened preterm labor, who after arrest of uterine activity were then randomized to progesterone therapy or no treatment and the purpose of this study was to determine whether supplementation of vaginal progesterone after inhibition of preterm labor is associated with an increased latency period and a decreased recurrent of preterm labor. Treatment group received progesterone suppository (400 mg) daily until delivery and control group received no treatment. The study concluded that the use of vaginal progesterone suppository after successful parenteral tocolysis associated with a longer latency preceding delivery but failed to reduce the incidence of readmission for preterm labor. Dydrogesterone supplementation in women with threatened had preterm delivery the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. [18]

A study on eighty-three women with symptoms of threatened preterm birth were either randomized to study groups receiving tocolytic treatment combined with intravaginal micronized natural progesterone (200 mg daily) or to a control group receiving only tocolysis. Micronized natural progesterone treatment resulted in a prolonged latency period of 32.1±17.8 versus 21.2±16.3 days in the control group and heavier birth weights of 2,982.8±697.8 g versus 2,585.3±746.6 g. [19]

Estradiol supplementation during the luteal phase of in vitro fertilization cycles

A prospective randomized study was done to find the optimal dosage of estradiol (E2) for luteal phase support through the addition of different doses of E2 to progesterone (P) luteal phase support in patients undergoing long GnRH agonist in vitro fertilization (IVF) treatments. [20] Two hundred and eighty-five women undergoing IVF treatment with a long GnRH agonist protocol were prospectively randomized into three groups. Group 1 (n=95) received P and 2 mg E2, group 2 (n=95) received P and 4 mg E2 and group 3 (n=95) received P and 6 mg E2 as luteal phase support. The primary outcome was the clinical pregnancy rate (PR). The secondary variables of interest were the implantation rate (IR), miscarriage rate and multiple PR. The clinical PR was 31.6%, 40% and 32% respectively in groups 1, 2 and 3 and the differences between groups were not statistically significant. However, the miscarriage rate was significantly lower in group 2 (2.6%) than in group 1 (20%) but was not significantly lower than in group 3 (9.6%). The study concluded that the in luteal phase adding 2, 4 or 6 mg of oral E2 to P creates no statistical difference in terms of pregnancy rates. However, a significantly higher miscarriage rate was found when 2 mg E2 was used. Therefore, in the luteal phase support, 4 mg of oral estradiol in addition to progesterone can be considered to reduce the miscarriage rate. More research is still required on identification of at risk group, the optimal gestational age at initiation, mode of administration, dose of progesterone and long-term safety.

Thyroid disorders

This has a great impact on fertility. Sex hormone-binding globulin (SHBG) is altered with hyperthyroidism and hypothyroidism. It also changes prolactin, gonadotropin-releasing hormone, and sex steroid serum levels. It may also have a direct effect on oocytes, because it is known that specific binding sites for thyroxin are found on mouse and human oocytes. There is also an association between thyroid dysfunction in women and morbidity and outcome in pregnancy. In males, hyperthyroidism causes a reduction in sperm motility. The numbers of morphologically abnormal sperm are increased by hypothyroidism. It has been found that when euthyroidism is restored, both abnormalities improve or normalize. In women, the alterations in fertility caused by thyroid disorders are more complex. Hyper- and hypothyroidism are the main thyroid diseases that have an adverse effect on female reproduction and cause menstrual disturbances-mainly hypomenorrhea and polymenorrhea in hyperthyroidism, and oligomenorrhea in hypothyroidism. All factors may be connected to the alterations in the metabolic pathway. Adequate levels of circulating thyroid hormones are of primary importance for normal reproductive function. [21]

Controlled ovarian hyperstimulation leads to increases in estradiol, which in turn may have an adverse effect on thyroid hormones and TSH. Ovarian hyperstimulation may become severe when autoimmune thyroid disease is present, depending on preexisting thyroid abnormalities. Autoimmune thyroid disease is present in 5-20% of unselected pregnant women. Isolated hypothyroxinemia has been described in approximately 2% of pregnancies, without serum TSH elevation and in the absence of thyroid auto antibodies. There is an association of increased rates of spontaneous abortion, premature delivery and/or low birth weight, fetal distress in labor, and perhaps gestation-induced hypertension and placental abruption in overt hypothyroidism. All antithyroid drugs cross the placenta and may potentially affect fetal thyroid function. [22]

Thyroid disorders are common in women during pregnancy. If left untreated, both hypothyroidism and hyperthyroidism are associated with adverse effects on pregnancy and fetal outcomes. It is important to correctly identify these disorders and treat them appropriately to prevent pregnancy-related complications. Indicated treatment is Levothyroxine for hypothyroidism, and thioamides are the treatment of choice for hyperthyroidism; thyroidectomy may be indicated in select cases. [23],[24] Cochrane review of three RCTs involving 314 women showed in one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia but did significantly reduce preterm birth by 72%. One trial of 30 hypothyroid women compared levothyroxine doses, but only reported biochemical outcomes. A trial of 169 women compared the trace element selenomethionine (selenium) with placebo and no significant differences were seen for either pre-eclampsia or preterm birth. None of the three trials reported on childhood neurodevelopmental delay. [25]

   Conclusion Top

Sex steroids are the best known examples of hormones and hence the review is concentrating on these. Progesterone is indispensable in creating a suitable endometrial environment for implantation, and also for the maintenance of pregnancy. Successful pregnancy depends on an appropriate maternal immune response to the fetus. Progestogen supplementation should be used preferentially within the context of a clinical trial or, in selected cases, in a kind of pragmatic approach, because progestogen treatment seems to be without remarkable adverse effects and as no 'better' treatment exists to date. Adequate levels of circulating thyroid hormones are of primary importance for normal reproductive function

   References Top

1.Csapo AL, Pulkkinen MO, Wiest WG, Effects of luteectomy and progesterone replacement in early pregnant patients. Am J Obstet Gynecol 1973;115:759.  Back to cited text no. 1
2.Schneider MA, Davies MC, Honour JW. The timing of placental competence in pregnancy after oocyte donation, Fertil Steril 1993;59:1059.  Back to cited text no. 2
3.Rothchild I. Role of progesterone in initiating and maintaining pregnancy. In: Bardin CW, Milgrom E, Mauvais-Jarvis P, editors. Progesterone and Progestins. New York: Raven Press; 1983. p. 219.  Back to cited text no. 3
4.Drake PM, Gunn MD, Charo IF, Tsou, CL, Zhou Y, Huang L, et al. Human placental cytotrophoblasts attract monocytes and CD56 (bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med 2001;193:1199-212.  Back to cited text no. 4
5.Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 2011;12:CD005943.  Back to cited text no. 5
6.El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas 2009;65(Suppl 1):S43-6.  Back to cited text no. 6
7.Reznikoff-Etievant MF, Zittoun J, Vaylet C, Pernet P, Milliez J. Low vitamin B12 level as risk factor for very early recurrent abortion. Eur J Obstet Gynecol Reprod Biol 2002;104:156-9.  Back to cited text no. 7
8.Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997;12:387-9.  Back to cited text no. 8
9.Katharina T. Walch, Johannes C. Huber. Progesterone for recurrent miscarriage. Best Pract Res Clin Obstetr Gynaecol 2008;22:375-89.  Back to cited text no. 9
10.Proctor A, Bradley S. Hurst, Paul B. Marshburn, Michelle L. Matthews. Effect of progesterone supplementary in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertil Steril 2006;85:1550-2.  Back to cited text no. 10
11.Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 2004;3:CD004830.  Back to cited text no. 11
12.van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011;10:CD009154.  Back to cited text no. 12
13.Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 Alpha - Hydroxyprogesterone caproate. New Engl J Med 2003;348:2379-85.  Back to cited text no. 13
14.How HY, Sibai BM. Progesterone for the prevention of preterm birth: Indications, when to initiate, efficacy and safety. Ther Clin Risk Manag 2009;5:55-64.  Back to cited text no. 14
15.Von Eye Corleta H, Capp E, Ferreira MB. Pharmacokinetics of natural progesterone vaginal suppository. Gynecol Obstet Invest 2004;58:105-8.  Back to cited text no. 15
16.Di Renzo GC, Mattei A, Gojnic M, Gerli S. Progesterone and pregnancy. Curr Opin Obstet Gynecol 2005;17:598-600.  Back to cited text no. 16
17.Borna S, Sahab N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomized control trial. Aust N Z J Obstet Gynaecol 2008;48:58-63.  Back to cited text no. 17
18.Hudiæ I, Szekeres-Bartho J, Fatušiæ Z, Stray-Pedersen B, Dizdareviæ-Hudiæ L, Latifagiæ A. Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile and progesterone - induced blocking factor. J Reprod Immunol 2011;92:103-7.  Back to cited text no. 18
19.Arikan I, Barut A, Harma M, Harma IM. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecol Obstet Invest 2011;72:269-73.  Back to cited text no. 19
20.Tonguc E, Var T, Ozyer S, Citil A, Dogan M. Estradiol supplementation during the luteal phase of in vitro fertilization cycles: A prospective randomised study. Eur J Obstet Gynecol Reprod Biol 2011;154:172-6.  Back to cited text no. 20
21.Dittrich R, Beckmann MW, Oppelt PG, Hoffmann I, Lotz L, Kuwert T, et al. Thyroid hormone receptors and reproduction. J Reprod Immunol 2011;90:58-66.  Back to cited text no. 21
22.Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-55.  Back to cited text no. 22
23.Yazbeck CF, Sullivan SD. Thyroid disorders during pregnancy. Med Clin North Am 2012;96:235-56.  Back to cited text no. 23
24.Vissenberg R, van den Boogaard E, van Wely M, van der Post JA, Fliers E, Bisschop PH, et al. Treatment of thyroid disorders before conception and in early pregnancy: A systematic review. Hum Reprod Update 2012;18:360-73.  Back to cited text no. 24
25.Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev 2010;(7):CD007752.  Back to cited text no. 25

This article has been cited by
1 FIGO Good Practice Recommendations on the use of progesterone in the management of recurrent first-trimester miscarriage
Hassan Shehata, Abdullatif Elfituri, Stergios K. Doumouchtsis, Mudiaga Eseajeberuo Zini, Amanda Ali, Haider Jan, Ramesh Ganapathy, Hema Divakar, Moshe Hod
International Journal of Gynecology & Obstetrics. 2023; 161(S1): 3
[Pubmed] | [DOI]
2 Chromosomal and gonadal factors regulate microglial sex effects in the aging brain
Sarah R. Ocañas, Victor A. Ansere, Collyn M. Kellogg, Jose V.V. Isola, Ana J. Chucair-Elliott, Willard M. Freeman
Brain Research Bulletin. 2023;
[Pubmed] | [DOI]
3 Effect of monosodium glutamate on fetal development and progesterone level in pregnant Wistar Albino rats
Hadeer M. Shosha, Hala M. Ebaid, Eman A. Toraih, Heba M. A. Abdelrazek, Ranwa A. Elrayess
Environmental Science and Pollution Research. 2023;
[Pubmed] | [DOI]
4 Pregnancy Denial: Toward a New Understanding of the Underlying Mechanisms
Natalia Chechko, Elena Losse, Susanne Nehls
Current Psychiatry Reports. 2023;
[Pubmed] | [DOI]
5 Interaction of the pre- and postnatal environment in the maternal immune activation model
Anna Gundacker, Laura Cuenca Rico, Peter Stoehrmann, Katharina E. Tillmann, Ulrike Weber-Stadlbauer, Daniela D. Pollak
Discover Mental Health. 2023; 3(1)
[Pubmed] | [DOI]
6 The Relationship Between Heavy Metals and Missed Abortion: Using Mediation of Serum Hormones
Haixia Liu, Zhilan Li, Li’ao Xie, Guangzhuang Jing, Weitao Liang, Jie He, Yuhui Dang
Biological Trace Element Research. 2023;
[Pubmed] | [DOI]
7 Gut Microbial Succession Patterns and Metabolic Profiling during Pregnancy and Lactation in a Goat Model
Ke Zhang, Gongwei Liu, Yujiang Wu, Ting Zhang, Mengmeng Guo, Yu Lei, Xi Cao, Langda Suo, Daniel Brugger, Xiaolong Wang, Yuxin Yang, Yulin Chen, Diyan Li
Microbiology Spectrum. 2023;
[Pubmed] | [DOI]
8 Electrochemical biosensors for monitoring of selected pregnancy hormones during the first trimester: A systematic review
Pernille Hagen Høj, Jon Møller-Sørensen, Alberte Lund Wissing, Fatima AlZahra'a Alatraktchi
Talanta. 2023; : 124396
[Pubmed] | [DOI]
9 Effect of 3a-dihydroprogesterone and 5a-dihydroprogesterone on DCIS cells and possible impact for postmenopausal women
M. Sourouni, M. Götte, L. Kiesel, M.-K. von Wahlde
Climacteric. 2023; : 1
[Pubmed] | [DOI]
10 Microvascular proliferation in arteriovenous malformation of the hand worsens during pregnancy: a case report
Amalia M. Utami, Sophie E.R. Horbach, Lorine B. Meijer-Jorna, Ingeborg S.E. Waas, Onno J. de Boer, Allard C. van der Wal, Chantal M.A.M. van der Horst
Annals of Medicine & Surgery. 2023; 85(4): 1262
[Pubmed] | [DOI]
11 Reproduction of domestic cats in laboratories, catteries, and feral colonies: A review
Theros T Ng, Andrea J Fascetti, Jennifer A Larsen
Topics in Companion Animal Medicine. 2023; : 100780
[Pubmed] | [DOI]
12 Maternal supplementation with human milk-derived Lactiplantibacillus plantarum WLPL04 affects the immunity and gut microbiota of offspring rats
Changcheng Zhong, Qianhui Wang, Yao He, Xiangxiang Zhao, Yanghong Wang, Lihua He, Hua Wei, Xueying Tao
Food & Function. 2023;
[Pubmed] | [DOI]
13 The hormonal physiology of immune components in breast milk and their impact on the infant immune response
Mextli Y. Bermejo-Haro, Rodrigo T. Camacho-Pacheco, Yesenia Brito-Pérez, Ismael Mancilla-Herrera
Molecular and Cellular Endocrinology. 2023; 572: 111956
[Pubmed] | [DOI]
14 Association of reproductive factors and exogenous hormone use with distal sensory polyneuropathy among postmenopausal women in the United States: results from 1999 to 2004 NHANES
Jiayu Li, Yuda Chongpison, Jakkrit Amornvit, Sukanya Chaikittisilpa, Somsook Santibenchakul, Unnop Jaisamrarn
Scientific Reports. 2023; 13(1)
[Pubmed] | [DOI]
15 Microbiome Changes in Pregnancy Disorders
Luca Giannella, Camilla Grelloni, Dayana Quintili, Alessia Fiorelli, Ramona Montironi, Sonila Alia, Giovanni Delli Carpini, Jacopo Di Giuseppe, Arianna Vignini, Andrea Ciavattini
Antioxidants. 2023; 12(2): 463
[Pubmed] | [DOI]
16 Chromogranin A: An Endocrine Factor of Pregnancy
Michalina Bralewska, Tadeusz Pietrucha, Agata Sakowicz
International Journal of Molecular Sciences. 2023; 24(5): 4986
[Pubmed] | [DOI]
17 Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure
Rachel E. Hudson, Torri D. Metz, Robert M. Ward, Autumn M. McKnite, Elena Y. Enioutina, Catherine M. Sherwin, Kevin M. Watt, Kathleen M. Job
Frontiers in Pharmacology. 2023; 14
[Pubmed] | [DOI]
18 Reduction in CgA-Derived CST Protein Level in HTR-8/SVneo and BeWo Trophoblastic Cell Lines Caused by the Preeclamptic Environment
Michalina Bralewska, Tadeusz Pietrucha, Agata Sakowicz
International Journal of Molecular Sciences. 2023; 24(8): 7124
[Pubmed] | [DOI]
19 Haematological, serum biochemical and hormonal profile in West African Dwarf goats during pregnancy
Olalekan Oluseyi Shittu, Ngozi Okwelum, Samuel Ayodele Famakinde, Adebisi Joshua Odeyemi, Dedewanu Peter Toviesi
Agricultura Tropica et Subtropica. 2023; 56(1): 50
[Pubmed] | [DOI]
20 Prevalence of Culturable Bacteria and Yeasts in the Nasopharynx Microbiota during the Physiological Course of Pregnancy
Urszula Kosikowska, Dominik Franciszek Dluski, Dorota Pietras-Ozga, Bozena Leszczynska-Gorzelak, Sylwia Andrzejczuk
Journal of Clinical Medicine. 2023; 12(13): 4447
[Pubmed] | [DOI]
21 Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus
Xuejing Lyu, Shaona Wang, Jiaxin Zhong, Lingzhu Cai, Yanhui Zheng, Ying Zhou, Ying Zhou, Qionghua Chen, Qiyuan Li
Frontiers in Microbiology. 2023; 14
[Pubmed] | [DOI]
22 Dengue in Pregnancy: A Southeast Asian Perspective
Vanessa Chong, Jennifer Zi Ling Tan, Valliammai Jayanthi Thirunavuk Arasoo
Tropical Medicine and Infectious Disease. 2023; 8(2): 86
[Pubmed] | [DOI]
23 GDF-11 downregulates placental human chorionic gonadotropin expression by activating SMAD2/3 signaling
Ze Wu, Lingling Zhang, Yuanyuan Jia, Beibei Bi, Lanlan Fang, Jung-Chien Cheng
Cell Communication and Signaling. 2023; 21(1)
[Pubmed] | [DOI]
24 Chloroform Fraction of Drymaria cordata Linn (CFDC) Suppresses Estradiol Benzoate- Induced Endometrial Hyperplasia
Adeola Oluwakemi Olowofolahan, Oluwatofunmi Akinjiola, John Oludele Olanlokun, Olubukola Titilope Oyebode, Oluwasanmi Olayinka Aina, Olufunso Olabode Olorunsogo
Anti-Cancer Agents in Medicinal Chemistry. 2023; 23(11): 1298
[Pubmed] | [DOI]
25 The Influence of Socio-Economic Factors on Diet and Active Lifestyle in the Spanish Female Population
Elena Sandri, Eva Cantín Larumbe, Germán Cerdá Olmedo
Nutrients. 2023; 15(15): 3319
[Pubmed] | [DOI]
26 The effects of female sex hormones on the human cornea across a woman’s life cycle
Donel S. Kelly, Sabhyta Sabharwal, David J. Ramsey, Melina I. Morkin
BMC Ophthalmology. 2023; 23(1)
[Pubmed] | [DOI]
27 Maternal inflammatory, lipid and metabolic markers and associations with birth and breastfeeding outcomes
Sophie Hilario Christensen, Ane Lilleøre Rom, Tine Greve, Jack Ivor Lewis, Hanne Frøkiær, Lindsay H. Allen, Christian Mølgaard, Kristina Martha Renault, Kim F. Michaelsen
Frontiers in Nutrition. 2023; 10
[Pubmed] | [DOI]
28 Unveiling the Effects of Triptorelin on Endocrine Profiles: Insights From Healthy, Polycystic Ovary Syndrome, and Hypothalamic Amenorrhea Women
Riya Kumari, Komal N Muneshwar, Aniket G Pathade, Seema Yelne
Cureus. 2023;
[Pubmed] | [DOI]
29 Hypertensive Disorders of Pregnancy: Assessing the Significance of Lp(a) and ApoB Concentrations in a Romanian Cohort
Simona-Alina Abu-Awwad, Marius Craina, Lioara Boscu, Elena Bernad, Paula Diana Ciordas, Catalin Marian, Mircea Iurciuc, Ahmed Abu-Awwad, Stela Iurciuc, Brenda Bernad, Diana Maria Anastasiu Popov, Anca Laura Maghiari
Journal of Personalized Medicine. 2023; 13(9): 1416
[Pubmed] | [DOI]
30 Evaluation of alpha amylase and peroxidase in saliva of pregnant women
Al-zahraa J Jassim, Zainab A Al Dhaher, Faten M Allyan
Journal of Baghdad College of Dentistry. 2023; 35(3): 21
[Pubmed] | [DOI]
31 Maternal and neonatal risk factors for aortic coarctation (a review)
E.S. Lyashko, A.T. Khaindrava, R.R. Arustamyan, O.V. Konysheva, M.S. Tsyganova, N.N. Lukina
Problemy reproduktsii. 2023; 29(4): 30
[Pubmed] | [DOI]
32 Implication of red meat consumption habits in serum uric acid levels and mood disorders among first-trimester pregnant women
Mudi H. Alharbi, Nora H.J. Alharbi, Ibtihal A. Brnawi, Elham H. Atiq
BMC Nutrition. 2023; 9(1)
[Pubmed] | [DOI]
33 Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
Sanjay Basak, Saikanth Varma, Asim K. Duttaroy
Frontiers in Endocrinology. 2023; 14
[Pubmed] | [DOI]
34 Oral hygiene and salivary IgA in relation to gingival condition in pregnant women
Saja Ali Hussein, Athraa Alwaheb
Bionatura. 2023; 8(CSS 4): 1
[Pubmed] | [DOI]
35 Endocrine disorders and fertility and pregnancy: An update
Anna Bendarska-Czerwinska, Nikola Zmarzly, Emilia Morawiec, Agata Panfil, Kamil Brys, Justyna Czarniecka, Aleksander Ostenda, Konrad Dziobek, Dorota Sagan, Dariusz Boron, Piotr Michalski, Veronica Pallazo-Michalska, Beniamin Oskar Grabarek
Frontiers in Endocrinology. 2023; 13
[Pubmed] | [DOI]
36 Endometriosis. Is spontaneous pregnancy possible with ovarian endometriosis?
O.Ya. Slobodyanik, A.S. Demyanenko, O.Yu. Kostenko, I.V. Poladych, I.V. Guzhevska
Reproductive health of woman. 2022; (6): 31
[Pubmed] | [DOI]
37 Early Serum Progesterone Measurement on 9th Day after Oocyte Retrieval can be used as a Predictor of Fresh Intracytoplasmic Sperm Injection Cycle Success
Shereen Abdulhussien Kzar, Zainab Khafajy, Shatha Sadiq Al-Marayaty
Open Access Macedonian Journal of Medical Sciences. 2022; 10(B): 36
[Pubmed] | [DOI]
38 Gut microbiota in gastrointestinal diseases during pregnancy
Zhong-Zhen Liu, Jing-Hua Sun, Wen-Jing Wang
World Journal of Clinical Cases. 2022; 10(10): 2976
[Pubmed] | [DOI]
39 Obesity and Maternal-Placental-Fetal Immunology and Health
Meredith Monaco-Brown, David A. Lawrence
Frontiers in Pediatrics. 2022; 10
[Pubmed] | [DOI]
40 Oversight and Management of Women with Psoriasis in Childbearing Age
?tefana Bucur, Alexandra-Petru?a Savu, Ana Maria Alexandra Stanescu, Elena-Daniela ?erban, Alin-Codru? Nicolescu, Traian Constantin, Anca Bobirca, Maria-Magdalena Constantin
Medicina. 2022; 58(6): 780
[Pubmed] | [DOI]
41 Urticaria in Pregnancy and Lactation
Emek Kocatürk, Indrashis Podder, Ana C. Zenclussen, Alicja Kasperska Zajac, Daniel Elieh-Ali-Komi, Martin K. Church, Marcus Maurer
Frontiers in Allergy. 2022; 3
[Pubmed] | [DOI]
42 Sex Hormones, Sleep, and Memory: Interrelationships Across the Adult Female Lifespan
Yasmin A. Harrington, Jeanine M. Parisi, Daisy Duan, Darlynn M. Rojo-Wissar, Calliope Holingue, Adam P. Spira
Frontiers in Aging Neuroscience. 2022; 14
[Pubmed] | [DOI]
43 Diagnosing Arterial Stiffness in Pregnancy and Its Implications in the Cardio-Renal-Metabolic Chain
Vladiana-Romina Turi, Constantin Tudor Luca, Dan Gaita, Stela Iurciuc, Izabella Petre, Mircea Iurciuc, Tunde Horvath, Dragos Cozma
Diagnostics. 2022; 12(9): 2221
[Pubmed] | [DOI]
44 The Joint Effect of Perceived Psychosocial Stress and Phthalate Exposure on Hormonal Concentrations during the Early Stage of Pregnancy: A Cross-Sectional Study
Henrieta Hlisníková, Miroslava Nagyová, Branislav Kolena, Miloš Mlyncek, Tomáš Trnovec, Ida Petrovicová
Children. 2022; 9(10): 1561
[Pubmed] | [DOI]
45 Vaginal microbiome: considerations for reproductive health
Chitrakshi Chopra, Indu Bhushan, Malvika Mehta, Tanvi Koushal, Amita Gupta, Sarika Sharma, Manoj Kumar, Souhaila Al Khodor, Sandeep Sharma
Future Microbiology. 2022;
[Pubmed] | [DOI]
46 Analytical Validation of the IMMULITE® 2000 XPi Progesterone Assay for Quantitative Analysis in Ovine Serum
Kristi L. Jones, Ameer A. Megahed, Brittany N. Diehl, Ann M. Chan, Oscar Hernández, Catalina Cabrera, João H. J. Bittar
Animals. 2022; 12(24): 3534
[Pubmed] | [DOI]
47 Pre-conceptional exposure to glyphosate affects the maternal hepatic and ovarian proteome
Gulnara Novbatova, Kelsey Timme, Andrew Severin, Maryam Sayadi, Aileen F Keating
Toxicological Sciences. 2022;
[Pubmed] | [DOI]
48 Modelling Female Physiology from Head to Toe: Impact of Sex Hormones, Menstrual Cycle, and Pregnancy
Stéphanie Abo, Delaney Smith, Melissa Stadt, Anita Layton
Journal of Theoretical Biology. 2022; : 111074
[Pubmed] | [DOI]
49 Progesterone Changes the Pregnancy-Induced Adaptation of Cardiomyocyte Kv2.1 Channels via MicroRNA-29b
Shuang Liang, Yu-Shuang Sun, Lu Li, Yao Long, Meng Wang, Hou-Zhi Yang, Chun-Di Li, Yan Wang, Shan-Shan Li, Xu Chen, Xin Jin, Simona Saponara
Cardiovascular Therapeutics. 2022; 2022: 1
[Pubmed] | [DOI]
50 The Role of Progesterone Receptor Isoforms in the Myometrium
Wan-Ning Li, Mackenzie J. Dickson, Francesco J. DeMayo, San-Pin Wu
The Journal of Steroid Biochemistry and Molecular Biology. 2022; : 106160
[Pubmed] | [DOI]
51 The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition
A. J. Giudicessi, U. G. Saelzler, A. H. Shadyab, A. I. B. Posis, E. E. Sundermann, S. J. Banks, M. S. Panizzon
Climacteric. 2022; : 1
[Pubmed] | [DOI]
52 Associations between psychological distress and hair cortisol during pregnancy and the early postpartum: A meta-analysis
Jennifer E. Khoury, Lauren Giles, Hargun Kaur, Dylan Johnson, Andrea Gonzalez, Leslie Atkinson
Psychoneuroendocrinology. 2022; : 105969
[Pubmed] | [DOI]
53 An increased proportion of progesterone receptor A in peripheral B cells from women who ultimately underwent spontaneous preterm birth
Kim-Norina Jutta Campe, Anke Redlich, Ana Claudia Zenclussen, Mandy Busse
Journal of Reproductive Immunology. 2022; : 103756
[Pubmed] | [DOI]
54 Exposure to perfluoroalkyl substances was associated with estrogen homeostasis in pregnant women
Jiaqi Yang,Hexing Wang,Hongyi Du,Hongji Fang,Minghui Han,Yuanping Wang,Linji Xu,Shuping Liu,Jianping Yi,Yue Chen,Qingwu Jiang,Gengsheng He
Science of The Total Environment. 2022; 805: 150360
[Pubmed] | [DOI]
55 Respiratory physiology in pregnancy and assessment of pulmonary function
Antonella LoMauro, Andrea Aliverti
Best Practice & Research Clinical Obstetrics & Gynaecology. 2022;
[Pubmed] | [DOI]
56 Association of age at first birth and risk of non-alcoholic fatty liver disease in women: evidence from the NHANES
Huan-Huan Yang, Guo-Chong Chen, Meng-Ge Zhou, Li-Feng Xie, Yuan-Yuan Jin, Hao-Tian Chen, Ze-Kun Chen, Yu-Hao Kong, Chang-Zheng Yuan, Zhi-Hui Li
Hepatology International. 2022;
[Pubmed] | [DOI]
57 Development of Electroanalytical Methods Using Different Electrodes for the Determination of Progesterone (P4) in Pharmaceutical Formulations and Human, Cow and Goat Milk
Victoria Cruz, Juan José Triviño, Verónica Arancibia
Electroanalysis. 2022;
[Pubmed] | [DOI]
58 Increased child-evoked activation in the precuneus during facial affect recognition in mothers
Irene Sophia Plank, Catherine Hindi Attar, Stefanie Lydia Kunas, Felix Bermpohl, Isabel Dziobek
Human Brain Mapping. 2022;
[Pubmed] | [DOI]
59 Mimics of cancer in pregnancy
Kristen Olinger, Ekta Maheshwari, Anuradha S. Shenoy-Bhangle, Margaret Adejolu, Melissa McGettigan, Hannah Mathew, Karen S. Lee, Refky Nicola
Abdominal Radiology. 2022;
[Pubmed] | [DOI]
60 Cord blood levels of interleukin-10 decrease in neonates with increased birth weight: novel implications of the cytokine network in early obesity
Lucía Angélica Méndez-García,Halili Minor-Borrego,Ana Laura Sánchez-Del Real,José Alfredo Aguayo-Guerrero,Tania Alvarado-Monroy,Fernanda Trejo-Millán,Jahaziel Rosas-Salinas,Salma Alejandra Rizo-Tellez,Sergio Islas-Andrade,Juan Carlos Briones-Garduño,José Manuel Fragoso,Galileo Escobedo
European Journal of Pediatrics. 2021;
[Pubmed] | [DOI]
61 Changes in Severity of Depression and Borderline Personality Disorder Symptoms from Pregnancy to Three Years Postpartum in Adolescent Mothers
Sierra Nannini,Irene Tung,Jessie B. Northrup,Stephanie D. Stepp,Kate Keenan,Alison E. Hipwell
Journal of Affective Disorders. 2021;
[Pubmed] | [DOI]
62 Mitochondria as the target for disease related hormonal dysregulation
Gladys A. Shaw
Brain, Behavior, & Immunity - Health. 2021; 18: 100350
[Pubmed] | [DOI]
63 Chorionic gonadotropin stimulates maternal hepatocyte proliferation during pregnancy
Jaeyong Cho,Yuji Tsugwa,Yumi Imai,Takeshi Imai
Biochemical and Biophysical Research Communications. 2021;
[Pubmed] | [DOI]
64 Killing two birds with one stone: Pregnancy is a sensitive window for endocrine effects on both the mother and the fetus
Isabelle Plante, Louise M. Winn, Cathy Vaillancourt, Petya Grigorova, Lise Parent
Environmental Research. 2021; : 112435
[Pubmed] | [DOI]
65 The impact of Di-(2-ethylhexyl) Phthalate and Mono(2-ethylhexyl) Phthalate in placental development, function, and pathophysiology
Luis Daniel Martínez-Razo, Alejandra Martínez-Ibarra, Edgar Ricardo Vázquez-Martínez, Marco Cerbón
Environment International. 2021; 146: 106228
[Pubmed] | [DOI]
66 Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy
Michalina Bralewska,Lidia Biesiada,Mariusz Grzesiak,Magda Rybak-Krzyszkowska,Hubert Huras,Agnieszka Gach,Tadeusz Pietrucha,Agata Sakowicz
BMC Pregnancy and Childbirth. 2021; 21(1)
[Pubmed] | [DOI]
67 Sex and gender in pulmonary arterial hypertension
Céline Cheron, Susan Ainslie McBride, Fabrice Antigny, Barbara Girerd, Margot Chouchana, Marie-Camille Chaumais, Xavier Jaïs, Laurent Bertoletti, Olivier Sitbon, Jason Weatherald, Marc Humbert, David Montani
European Respiratory Review. 2021; 30(162): 200330
[Pubmed] | [DOI]
68 Fetoplacental vasculature as a model to study human cardiovascular endocrine disruption
Margarida Lorigo, Elisa Cairrao
Molecular Aspects of Medicine. 2021; : 101054
[Pubmed] | [DOI]
69 Environmental Factors Involved in Maternal Morbidity and Mortality
Abee L. Boyles, Brandiese E. Beverly, Suzanne E. Fenton, Chandra L. Jackson, Anne Marie Z. Jukic, Vicki L. Sutherland, Donna D. Baird, Gwen W. Collman, Darlene Dixon, Kelly K. Ferguson, Janet E. Hall, Elizabeth M. Martin, Thaddeus T. Schug, Alexandra J. White, Kelly J. Chandler
Journal of Women's Health. 2021; 30(2): 245
[Pubmed] | [DOI]
70 Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
Grace Y. Lam,Jodi Goodwin,Pearce G. Wilcox,Bradley S. Quon
ERJ Open Research. 2021; 7(1): 00475-2020
[Pubmed] | [DOI]
71 Oral microbiome and pregnancy: a bidirectional relationship
Marwa Saadaoui,Parul Singh,Souhaila Al Khodor
Journal of Reproductive Immunology. 2021; : 103293
[Pubmed] | [DOI]
72 Soluble guanylate cyclase stimulation in late gestation does not mitigate asymmetric intrauterine growth restriction or cardiovascular risk induced by placental ischemia in the rat
Laura E. Coats,Bhavisha A. Bakrania,Daniel R. Bamrick-Fernandez,Allison M. Ariatti,Adam Z. Rawls,Norma B. Ojeda,Barbara T. Alexander
American Journal of Physiology-Heart and Circulatory Physiology. 2021; 320(5): H1923
[Pubmed] | [DOI]
73 Maternal omega-3 fatty acids maintained positive maternal lipids and cytokines profile, and improved pregnancy outcomes of C57BL/6 mice
Olatunji Anthony Akerele,Sarah Jane Manning,Sarah Emily Dixon,Amelia Estelle Lacey,Sukhinder Kaur Cheema
The Journal of Nutritional Biochemistry. 2021; : 108813
[Pubmed] | [DOI]
74 Amphiregulin stimulates human chorionic gonadotropin expression by inducing ERK1/2-mediated ID3 expression in trophoblast cells
Lanlan Fang,Sijia Wang,Xiaoyu Han,Yibo Gao,Yuxi Li,Jung-Chien Cheng,Ying-Pu Sun
Placenta. 2021; 112: 73
[Pubmed] | [DOI]
75 Omouma: a prospective mother and child cohort aiming to identify early biomarkers of pregnancy complications in women living in Qatar
Manoj Kumar,Marwa Saadaoui,Duaa Ahmed Elhag,Selvasankar Murugesan,Shaikha Al Abduljabbar,Yassin Fagier,Osman Ortashi,Hala Abdullahi,Ibrahim Ibrahim,Medhat Alberry,Anthony Abbas,Sawssan R. Ahmed,Mohamed A. Hendaus,Karim Kalache,Annalisa Terranegra,Souhaila Al Khodor
BMC Pregnancy and Childbirth. 2021; 21(1)
[Pubmed] | [DOI]
76 Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics
Rebecca Shepherd,Ada S. Cheung,Ken Pang,Richard Saffery,Boris Novakovic
Frontiers in Immunology. 2021; 11
[Pubmed] | [DOI]
77 Nutrient Requirements during Pregnancy and Lactation
Marie Jouanne,Sarah Oddoux,Antoine Noël,Anne Sophie Voisin-Chiret
Nutrients. 2021; 13(2): 692
[Pubmed] | [DOI]
78 Label-free detection of uptake, accumulation, and translocation of diesel exhaust particles in ex vivo perfused human placenta
Eva Bongaerts,Leonie Aengenheister,Battuja B. Dugershaw,Pius Manser,Maarten B. J. Roeffaers,Marcel Ameloot,Tim S. Nawrot,Hannelore Bové,Tina Buerki-Thurnherr
Journal of Nanobiotechnology. 2021; 19(1)
[Pubmed] | [DOI]
79 COVID-19 Infection during Pregnancy: Risk of Vertical Transmission, Fetal, and Neonatal Outcomes
Marwa Saadaoui,Manoj Kumar,Souhaila Al Khodor
Journal of Personalized Medicine. 2021; 11(6): 483
[Pubmed] | [DOI]
80 Hepatitis E and Pregnancy: An Unholy Alliance Unmasked from Kashmir, India
Mohammad Sultan Khuroo
Viruses. 2021; 13(7): 1329
[Pubmed] | [DOI]
81 The Expanding Role of Mitochondria, Autophagy and Lipophagy in Steroidogenesis
Geetika Bassi,Simarjit Kaur Sidhu,Suresh Mishra
Cells. 2021; 10(8): 1851
[Pubmed] | [DOI]
82 An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics
Ahizechukwu C. Eke
Journal of Basic and Clinical Physiology and Pharmacology. 2021; 0(0)
[Pubmed] | [DOI]
83 Crosstalk Between Female Gonadal Hormones and Vaginal Microbiota Across Various Phases of Women’s Gynecological Lifecycle
Harrisham Kaur,Mitali Merchant,Mohammed Monzoorul Haque,Sharmila S. Mande
Frontiers in Microbiology. 2020; 11
[Pubmed] | [DOI]
84 The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years
Yao Yao,Xiaoyu Cai,Chunyan Chen,Hui Fang,Yunchun Zhao,Weidong Fei,Fengying Chen,Caihong Zheng
Frontiers in Pharmacology. 2020; 11
[Pubmed] | [DOI]
85 Prevalence of Prenatal Depression Among Pregnant Women and the Importance of Resilience: A Multi-Site Questionnaire-Based Survey in Mainland China
Lijuan Zhang,Xiaoshi Yang,Jinfeng Zhao,Weiyu Zhang,Can Cui,Fengzhi Yang,Ruqing Ma,Yajing Jia
Frontiers in Psychiatry. 2020; 11
[Pubmed] | [DOI]
86 Maternal Microbiota, Cortisol Concentration, and Post-Partum Weight Recovery Are Dependent on Mode of Delivery
Marta Selma-Royo,Izaskun García-Mantrana,Marta Calatayud,Anna Parra-Llorca,Cecilia Martínez-Costa,María Carmen Collado
Nutrients. 2020; 12(6): 1779
[Pubmed] | [DOI]
87 Placental Regulation of Energy Homeostasis During Human Pregnancy
Brooke Armistead,Eugenia Johnson,Robert VanderKamp,Elzbieta Kula-Eversole,Leena Kadam,Sascha Drewlo,Hamid-Reza Kohan-Ghadr
Endocrinology. 2020; 161(7)
[Pubmed] | [DOI]
88 Recent insights on indirect mechanisms in developmental toxicity of nanomaterials
Battuja Batbajar Dugershaw,Leonie Aengenheister,Signe Schmidt Kjølner Hansen,Karin Sørig Hougaard,Tina Buerki-Thurnherr
Particle and Fibre Toxicology. 2020; 17(1)
[Pubmed] | [DOI]
89 Antiplasmodial activities and abortifacient properties of three commonly used African indigenous anti-malarial plants in Plasmodium berghei infected pregnant mice: implication for maternal and fetal health
Ayodele S. Babalola,Olufunmilayo A. Idowu,Kehinde O. Ademolu,J. Olukunle,Samson A. Rahman
Bulletin of the National Research Centre. 2020; 44(1)
[Pubmed] | [DOI]
90 Determinants of Sweetness Preference: A Scoping Review of Human Studies
Carolina Venditti,Kathy Musa-Veloso,Han Youl Lee,Theresa Poon,Alastair Mak,Maryse Darch,Justine Juana,Dylan Fronda,Daniel Noori,Erika Pateman,Maia Jack
Nutrients. 2020; 12(3): 718
[Pubmed] | [DOI]
91 Blood Vessels and Vascular Niches in Bone Development and Physiological Remodeling
Michelle Hendriks,Saravana K. Ramasamy
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed] | [DOI]
92 Maternal Microbiome and Infections in Pregnancy
Mohammed Amir,Julia A. Brown,Stephanie L. Rager,Katherine Z. Sanidad,Aparna Ananthanarayanan,Melody Y. Zeng
Microorganisms. 2020; 8(12): 1996
[Pubmed] | [DOI]
93 Shiftwork and Light at Night Negatively Impact Molecular and Endocrine Timekeeping in the Female Reproductive Axis in Humans and Rodents
Alexandra Yaw,Autumn McLane-Svoboda,Hanne Hoffmann
International Journal of Molecular Sciences. 2020; 22(1): 324
[Pubmed] | [DOI]
94 Fecal Cortisol and Progesterone Concentrations in Post Partus of Etawah Crossbreed Goat
Claude M. Airin,Amelia Hana,Sarmin Sarmin,Pudji Astuti,G. Gholib,A. Sutriana,A. Engelhardt,J. Duboscq,R. Sahara Zamzami
E3S Web of Conferences. 2020; 151: 01031
[Pubmed] | [DOI]
95 Determination of minimal recording period to assess resting heart rate variability during pregnancy
Danilo Fernandes da Silva,Shuhiba Mohammad,Kelly Ann Hutchinson,Kristi Bree Adamo
Applied Physiology, Nutrition, and Metabolism. 2020; 45(4): 431
[Pubmed] | [DOI]
96 Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy
Jeremy Gingrich,Elvis Ticiani,Almudena Veiga-Lopez
Trends in Endocrinology & Metabolism. 2020;
[Pubmed] | [DOI]
97 WHO type 1 anovulation: an update on diagnosis, management and implications for long-term health
Vikram Talaulikar,Ephia Yasmin
The Obstetrician & Gynaecologist. 2020;
[Pubmed] | [DOI]
98 Pharmacology for Preterm Labor
Lindsey Garfield,Emily Chin
The Journal of Perinatal & Neonatal Nursing. 2020; 34(2): 155
[Pubmed] | [DOI]
99 Re-evaluation of reproductive cycle and fecundity of finetooth sharks Carcharhinus isodon ( V alenciennes 1839) from the N orthwest A tlantic O cean, with new observations on ovarian cycle and reproductive endocrinology of biennially reproducing sharks
Amanda N. Brown,Bryan S. Frazier,Jim Gelsleichter
Journal of Fish Biology. 2020;
[Pubmed] | [DOI]
100 Hormone-balancing and protective effect of combined extract of Sauropus androgynus and Elephantopus scaber against E. coli-induced renal and hepatic necrosis in pregnant mice
Yuyun Ika Christina,Meyla Restia Diana,Eka Noviya Fuzianingsih,Eka Noviya Nurhayati,Faradisa Noviani Ridwan,Faradisa Noviani Widodo,Muhaimin Rifa’i,Muhammad Sasmito Djati
Journal of Ayurveda and Integrative Medicine. 2020;
[Pubmed] | [DOI]
101 Dietary synbiotic alters plasma biochemical parameters and fecal microbiota and metabolites in sows
Cui Ma,Wanghong Zhang,Qiankun Gao,Qian Zhu,Mingtong Song,Hao Ding,Yulong Yin,Xiangfeng Kong
Journal of Functional Foods. 2020; 75: 104221
[Pubmed] | [DOI]
102 LC-MS/MS Method for Rapid Quantification of Progesterone in Rabbit Plasma and Its Application in a Pharmacokinetic Study of the Transdermal Formulation
Cao-Son Tran,Quang-Dong Bui,Ngoc-Tho Thi Nguyen,Minh-Hanh Dao,Thach-Tung Nguyen,Tien Duc Pham
Journal of Analytical Methods in Chemistry. 2020; 2020: 1
[Pubmed] | [DOI]
103 Oral Paracoccidioidomycosis affecting women: A systematic review
Matheus de Castro Costa,Milena Moraes de Carvalho,Felipe Fornias Sperandio,Noé Vital Ribeiro Junior,João Adolfo Costa Hanemann,Suzane Cristina Pigossi,Marina Lara de Carli
Mycoses. 2020;
[Pubmed] | [DOI]
104 Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?
Michelle Volovsky,Cassandra Pakes,Genia Rozen,Alex Polyakov
Journal of Assisted Reproduction and Genetics. 2020;
[Pubmed] | [DOI]
105 The Expression and Contribution of SRCs with Preeclampsia Placenta
Jea Sic Jeong,Dong Hyung Lee,Jae-Eon Lee,Sung-Min An,Pyong In Yi,Geun-Shik Lee,Dae Youn Hwang,Seung Yun Yang,Seung Chul Kim,Beum-soo An
Reproductive Sciences. 2020;
[Pubmed] | [DOI]
106 Pregnancy as a model for aging
Abram Giller,Mariana Andrawus,Danielle Gutman,Gil Atzmon
Ageing Research Reviews. 2020; 62: 101093
[Pubmed] | [DOI]
107 Associations between green space and preterm birth: Windows of susceptibility and interaction with air pollution
Yi Sun,Paige Sheridan,Olivier Laurent,Jia Li,David A. Sacks,Heidi Fischer,Yang Qiu,Yu Jiang,Ilona S. Yim,Luo-Hua Jiang,John Molitor,Jiu-Chiuan Chen,Tarik Benmarhnia,Jean M. Lawrence,Jun Wu
Environment International. 2020; 142: 105804
[Pubmed] | [DOI]
108 Comparison of Human Antral Follicles of Xenograft versus Ovarian Origin Reveals Disparate Molecular Signatures
Limor Man,Nicole Lustgarten-Guahmich,Eleni Kallinos,Zachary Redhead-Laconte,Sally Liu,Benjamin Schattman,David Redmond,Kolbe Hancock,Nikica Zaninovic,Glenn Schattman,Zev Rosenwaks,Daylon James
Cell Reports. 2020; 32(6): 108027
[Pubmed] | [DOI]
109 Elevated non-essential metals and the disordered metabolism of essential metals are associated to abnormal pregnancy with spontaneous abortion
Ruixia Wang,Le Zhang,Yongjiu Chen,Shuping Zhang,Taifeng Zhuang,Li Wang,Ming Xu,Na Zhang,Sijin Liu
Environment International. 2020; 144: 106061
[Pubmed] | [DOI]
110 Precision medicine in perinatal depression in light of the human microbiome
Beatriz Peñalver Bernabé,Pauline M. Maki,Shannon M. Dowty,Mariana Salas,Lauren Cralle,Zainab Shah,Jack A. Gilbert
Psychopharmacology. 2020;
[Pubmed] | [DOI]
111 Endometriosis in pregnancy
Ryan Navarro,Liina Poder,Derek Sun,Priyanka Jha
Abdominal Radiology. 2020;
[Pubmed] | [DOI]
112 Circadian rhythms in the mouse reproductive axis during the estrous cycle and pregnancy
Alexandra M. Yaw,Thu V. Duong,Duong Nguyen,Hanne M. Hoffmann
Journal of Neuroscience Research. 2020;
[Pubmed] | [DOI]
113 Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review
Vitaris Kodogo,Feriel Azibani,Karen Sliwa
Clinical Research in Cardiology. 2019;
[Pubmed] | [DOI]
114 The associations between prenatal exposure to triclocarban, phenols and parabens with gestational age and birth weight in northern Puerto Rico
Amira M. Aker,Kelly K. Ferguson,Zaira Y. Rosario,Bhramar Mukherjee,Akram N. Alshawabkeh,José F. Cordero,John D. Meeker
Environmental Research. 2019; 169: 41
[Pubmed] | [DOI]
115 Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy
Meital Nuriel-Ohayon,Hadar Neuman,Oren Ziv,Anna Belogolovski,Yiftah Barsheshet,Naamah Bloch,Atara Uzan,Roey Lahav,Avi Peretz,Sigal Frishman,Moshe Hod,Eran Hadar,Yoram Louzoun,Orly Avni,Omry Koren
Cell Reports. 2019; 27(3): 730
[Pubmed] | [DOI]
116 Resistance Training and Skeletal Muscle Protein Metabolism in Eumenorrheic Females: Implications for Researchers and Practitioners
Olivia E. Knowles,Brad Aisbett,Luana C. Main,Eric J. Drinkwater,Liliana Orellana,Séverine Lamon
Sports Medicine. 2019;
[Pubmed] | [DOI]
117 Heightened Susceptibility: A Review of How Pregnancy and Chemical Exposures Influence Maternal Health
Julia Varshavsky,Anna Smith,Aolin Wang,Elizabeth Hom,Monika Izano,Hongtai Huang,Amy Padula,Tracey J. Woodruff
Reproductive Toxicology. 2019;
[Pubmed] | [DOI]
118 Identification of loci associated with conception rate in primiparous Holstein cows
Jennifer N. Kiser,Erin Clancey,Joao G. N. Moraes,Joseph Dalton,Gregory W. Burns,Thomas E. Spencer,Holly L. Neibergs
BMC Genomics. 2019; 20(1)
[Pubmed] | [DOI]
119 Neurobiological changes during the peripartum period: implications for health and behavior
Emilia F Cárdenas,Autumn Kujawa,Kathryn L Humphreys
Social Cognitive and Affective Neuroscience. 2019;
[Pubmed] | [DOI]
120 Expression of steroidogenic enzymes in human placenta according to the gestational age
So-Hye Hong,Seung Kim,Mee-Na Park,Jea Jeong,Seung Yang,Young Lee,Ok-Nam Bae,Hoe-Saeng Yang,Sungbaek Seo,Kyu-Sup Lee,Beum-Soo An
Molecular Medicine Reports. 2019;
[Pubmed] | [DOI]
121 Preliminary data for performance in hue ordering tests during pregnancy
T.S.S. Calandrini,L. Miquilini,M.R. Laranjeiras-Neto,M.T.S. Tongu,M.P. Silva,G.S. Souza,M.I.T. Cortes
Brazilian Journal of Medical and Biological Research. 2019; 52(2)
[Pubmed] | [DOI]
122 Pilot study on patients with Mal de Debarquement syndrome during pregnancy
Viviana Mucci,Josephine M Canceri,Yves Jacquemyn,Angelique Van Ombergen,Leen K Maes,Paul H Van de Heyning,Cherylea J Browne
Future Science OA. 2019; : FSO377
[Pubmed] | [DOI]
123 Foeniculum vulgare as Valuable Plant in Management of Womenæs Health
Mohaddese Mahboubi
Journal of Menopausal Medicine. 2019; 25(1): 1
[Pubmed] | [DOI]
124 Higher ?-human chorionic gonadotropin and estrogen levels during the first 6 weeks of pregnancy are associated with threatened abortion
Ling Xu,Qun Wei,Qiong Wu,Yanbo Zhong,Yangfang Li,Jun Xu,Yunheng Zhu
BioScience Trends. 2019;
[Pubmed] | [DOI]
125 Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota
Qinghui Mu,Xavier Cabana-Puig,Jiangdi Mao,Brianna Swartwout,Leila Abdelhamid,Thomas E. Cecere,Haifeng Wang,Christopher M. Reilly,Xin M. Luo
Microbiome. 2019; 7(1)
[Pubmed] | [DOI]
126 Unraveling the Serum Metabolomic Profile of Post-partum Depression
Zoe Papadopoulou,Angeliki-Maria Vlaikou,Daniela Theodoridou,Chrysoula Komini,Georgia Chalkiadaki,Marina Vafeiadi,Katerina Margetaki,Theoni Trangas,Chris W. Turck,Maria Syrrou,Leda Chatzi,Michaela D. Filiou
Frontiers in Neuroscience. 2019; 13
[Pubmed] | [DOI]
Monika Pytka,Monika Kordowska-Wiater,Piotr Jarocki
Postepy Mikrobiologii - Advancements of Microbiology. 2019; 58(3): 227
[Pubmed] | [DOI]
128 Prostaglandin E2 receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
Yao Ye,Aurelia Vattai,Nina Ditsch,Christina Kuhn,Martina Rahmeh,Sven Mahner,Myriam Ripphahn,Roland Immler,Markus Sperandio,Udo Jeschke,Viktoria von Schönfeldt
Endocrine Connections. 2018; 7(5): 749
[Pubmed] | [DOI]
129 Keystone Species in Pregnancy Gingivitis: A Snapshot of Oral Microbiome During Pregnancy and Postpartum Period
Preethi Balan,Yap Seng Chong,Shivshankar Umashankar,Sanjay Swarup,Wong Mun Loke,Violeta Lopez,Hong Gu He,Chaminda Jayampath Seneviratne
Frontiers in Microbiology. 2018; 9
[Pubmed] | [DOI]
130 The dynamics of vaginal and rectal Lactobacillus spp. flora in subsequent trimesters of pregnancy in healthy Polish women, assessed using the Sanger sequencing method
Anna Dobrut,Tomasz Gosiewski,Wojciech Pabian,Malgorzata Bodaszewska-Lubas,Dorota Ochonska,Malgorzata Bulanda,Monika Brzychczy-Wloch
BMC Pregnancy and Childbirth. 2018; 18(1)
[Pubmed] | [DOI]
131 A Scalable and Versatile Synthesis of Oxime-Based Hormone Dimers and Gels for Sustained Release
Christopher W. Bennett,Joe Collins,Zeyun Xiao,Daniel Klinger,Luke A. Connal
Chemistry - An Asian Journal. 2017;
[Pubmed] | [DOI]
132 Prevalence and Relevance of Pruritus in Pregnancy
Justyna Szczech,Artur Wiatrowski,Lidia Hirnle,Adam Reich
BioMed Research International. 2017; 2017: 1
[Pubmed] | [DOI]
133 Assessment of liver function in pregnant anemic women upon oral iron and folic acid supplementation
A.K.M. Tiwari,A.A. Mahdi,S. Mishra
Journal of Gynecology Obstetrics and Human Reproduction. 2017;
[Pubmed] | [DOI]
134 Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review
Seema Patel
The Journal of Steroid Biochemistry and Molecular Biology. 2017;
[Pubmed] | [DOI]
135 Early microbiota, antibiotics and health
Alicja M. Nogacka,Nuria Salazar,Silvia Arboleya,Marta Suárez,Nuria Fernández,Gonzalo Solís,Clara G. de los Reyes-Gavilán,Miguel Gueimonde
Cellular and Molecular Life Sciences. 2017;
[Pubmed] | [DOI]
136 A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice
Damián Oscar Muzzio,Katrin Regina Helene Packhäuser,Gleyder Roman-Sosa,Jens Ehrhardt,Diana Krüger,Marek Zygmunt
Frontiers in Immunology. 2017; 8
[Pubmed] | [DOI]
137 Pregnancy promotes pituitary tumors by increasing the rate of the cell cycle
Changjiang Yin,Xiaoxia Qi
Oncology Letters. 2017; 14(4): 4873
[Pubmed] | [DOI]
138 Microbial Changes during Pregnancy, Birth, and Infancy
Meital Nuriel-Ohayon,Hadar Neuman,Omry Koren
Frontiers in Microbiology. 2016; 7
[Pubmed] | [DOI]
139 The effect of prenatally administered vaginal progesterone on uterine artery Doppler in asymptomatic twin pregnancies
Isabela K.R. Agra,Maria L. Brizot,Mariana Y. Miyadahira,Mário H.B. Carvalho,Rossana P.V. Francisco,Marcelo Zugaib
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016; 205: 11
[Pubmed] | [DOI]
140 Immune-endocrine crosstalk during pregnancy
Rohini R. Nair,Priyanka Verma,Kiran Singh
General and Comparative Endocrinology. 2016;
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded454    
    Comments [Add]    
    Cited by others 140    

Recommend this journal